SERTAD1 and hepatocellular carcinoma: In contrast to the above findings, TCSBN depicted that SERTAD1 is negatively correlated with TADA1 (Corr = −0.624), ICE2 (Corr = −0.629) and ATL2 (Corr = −0.429) in melanoma and HCC respectively (Table S5).